EGFR and non-small cell lung carcinoma: EGFR overexpression or abnormalities trigger sustained signal transduction, promoting cell survival, proliferation, relapse, tumorigenesis, and metastasis in NSCLC through the MAPK, PI3K/AKT, and signal transducer and activator of transcription (STAT) factors [10,11].